1996 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases

Thursday, May 16, 1996
The First Amendment Lounge, The National Press Club
14th and F Streets, NW, Washington, D.C.

Agenda

10:00 a.m.

About the National Foundation for Infectious Diseases (NFID) and the Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
William J. Martone, M.D.
Senior Executive Director, NFID
Bethesda, MD

10:05 a.m.

Introductory Comments
Richard J. Duma, M.D., Ph.D.
Member, Board of Trustees, NFID
Director, Infectious Diseases, Halifax Medical Center
Daytona Beach, FL

10:15 a.m.

The Continuous Threat of New and Emerging Infectious Diseases
Robert W. Pinner, M.D.
Special Assistant for Surveillance, National Center for Infectious Diseases,
Centers for Disease Control and Prevention
Atlanta, GA

10:35 a.m.

Antimicrobial Resistance: A National and Global Threat
Stuart B. Levy, M.D.
Professor of Medicine and of Molecular Biology & Microbiology
Director, Center for Adaptation Genetics & Drug Resistance, Tufts University School of Medicine
Author of The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle
Boston, MA

10:55 a.m.

New Tools to Detect Pathogens
David A. Relman, M.D.
Assistant Professor of Medicine, Microbiology, and Immunology, Stanford University School of Medicine
Veterans Administration Palo Alto Health Care System
Palo Alto, CA

11:15 a.m.

Late Breaker--Prions, Bovine Spongiform Encephalopathy ("Mad Cow Disease") and Human Health Risk
Frank O. Bastian, M.D.
Professor of Pathology and Director of Neuropathology, University of South Alabama
Mobile, AL

Linda Detwiler, D.V.M.
Veterinary Services, Animal and Plant Health Inspection Service,
U.S. Department of Agriculture
Riverdale, MD

11:30 a.m.

Questions to the Panel
Moderator--William J. Martone, M.D.

Each panelist will be asked for his prediction about breaking infectious disease news for 1997, followed by questions from the audience.

12:00 p.m.

Adjournment/Complimentary Lunch

The Richard J. Duma Annual Press Conference and Symposium on Infectious Diseases is supported in part by educational grants from Eli Lilly and Company and Pfizer Inc.